fashion -WSS

fashion

author：knowledge 2025-09-07 17:30:04 - browse：434

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Black vets could get higher VA benefits if race not used in lung test

Wikipedia

focus

WSS

Is it ever OK for doctors to lie to their patients?

Warren pushes Witty on UnitedHealth's control over physicians

Has Bernie Sanders reached the limit of his pharma bullying effort?

Roche’s Alnylam deal shows drug firms interested in heart drugs

Will the FTC rein in IQVIA's health data empire?

Crowdfunding for medical bills sidesteps core problem, author says

focus

fashion

focus

Heart attack and stroke risk calculators need revising

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Bright Health sells Medicare Advantage business to Molina

Is it ever OK for doctors to lie to their patients?

Alkermes shareholders re

The haunting brain science of long Covid

In age of alternative facts, a scholarly course on calling out crap

Will the FTC rein in IQVIA's health data empire?

Guidelines to prevent youth baseball injuries need more muscle

Search called off for baby washed away in Pennsylvania flash flood

focus

Rise in cancer among younger people worries and puzzles doctors

Democrats decry new health bill for going easy on private equity

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Primary care doctor shortage won't be solved by free med school tuition

Lawmakers grill UnitedHealth CEO on Change cyberattack

Device maker Teleflex to acquire urology company for $600M

Wikipedia

entertainment

focus

knowledge